Register for our free email digests:
GlaxoSmithKline PLC
www.gsk.com
Latest From GlaxoSmithKline PLC
EMA OKs Seven New Drugs But Delivers Another Blow To Emmaus
Seven new drugs have this week moved closer to gaining EU approval following positive recommendations from the European Medicines Agency, but Emmaus’ glutamine product has fared less well and the company is considering another route for getting the drug to sickle cell disease patients in Europe
Winter Is Coming: CHC Firms Battle It Out In Germany’s Crowded Cough And Cold Market
Less Success 'Expected' In 'OTC Setting' Trial For GSK's NRT, Expert Tells NDAC
While lower than results in GSK standard efficacy trial, 'real world' success still is clinically significant, firm's experts tell FDA advisory committee after agency officials asked the panel to consider whether the results translate to clinically meaningful benefit for GSK's proposed mouth spray NRT.
What’s At Stake As China Expands '4+7' Scheme: An Infographic Snapshot
China’s massive centralized "4+7" drug procurement scheme is now being rolled out nationwide, involving some of the largest provincial markets and huge product volumes.
Company Information
- Industry
-
Pharmaceuticals
- Vaccines
- Therapeutic Areas
- Cancer
- Cardiovascular
- Dermatology
- Immune Disorders
- Infectious & Viral Diseases
- Inflammation
- Metabolic Disorders
- Neurology, Nervous System
- Ophthalmic
- Respiratory, Pulmonary
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
Europe
-
Western Europe
-
UK
-
UK
-
Western Europe
-
Europe
- Company Type
- Big Pharma
- Parent & Subsidiaries
-
GlaxoSmithKline PLC
- Affymax NV
- AKE Pathologists
- Allen & Hanburys Ltd.
- American Medical Optics
- Block Drug Co. Inc.
- Bristol-Myers Squibb Pakistan Ltd.
- Britisfarma
- Burroughs Wellcome Co.
- Burroughs Wellcome Inc.
- Cellzome AG
- Center of Excellence for External Drug Discovery
- CNS Inc.
- Corixa Corp.
- Diversified Prescription Delivery
- Domantis Ltd.
- Galvani Bioelectronics
- Genelabs Technologies Inc.
- Glaxo Australia Pty. Ltd.
- Glaxo Canada-IAF Biochem Joint Venture
- Glaxo Group Research Ltd.
- Glaxo Hong Kong
- Glaxo Laboratories Ltd.
- Glaxo Research and Development Ltd.
- Glaxo Wellcome Inc.
- Glaxo Wellcome PLC
- Glaxo Wellcome SA
- Glaxo Wellcome SPA
- GlaxoSmithKline (China) Investment Co. Ltd.
- GlaxoSmithKline Biologicals SA
- GlaxoSmithKline Consumer Healthcare
- GlaxoSmithKline Inc.
- GlaxoSmithKline KK
- GlaxoSmithKline LLC
- GlaxoSmithKline Pharmaceuticals Ltd.
- GlycoVaxyn AG
- GSK Biologicals Shenzhen Co. Ltd.
- GSK Consumer Healthcare
- Human Genome Sciences Inc.
- ID Biomedical Corp.
- International Clinical Laboratories Inc.
- International Hydron Corp.
- Italmex
- Laboratorios Phoenix SA
- Lombart Optical of Virginia Ltd.
- Maxinutrition Group Holdings Ltd.
- Morrith SA
- Nanjing MeiRui Pharma Co. Ltd
- Nippon Glaxo Co. Ltd.
- Norcliff Thayer and Reheis
- Okairos AG
- Pathology and Cytology Laboratories
- Polfa Poznan SA
- Praecis Pharmaceuticals Inc.
- Puget Sound Institute of Pathology Inc.
- Reliant Pharmaceuticals Inc.
- Sachsisches Serumwerk GMBH
- Sirtris Pharmaceuticals Inc.
- SmithKline Beecham
- SmithKline Beecham Animal Health
- SmithKline Beecham Consumer Healthcare
- SmithKline Beecham Corp.
- SmithKline Beecham Healthcare Services
- SmithKline Beecham Pharmaceuticals
- SmithKline Beecham Pharmaceuticals R&D
- SmithKline Beecham Seiyaku KK
- SmithKline Bio-Science Laboratories
- SmithKline Diagnostics Inc.
- SmithKline-RIT
- Softsite Contact Lens Laboratory Inc.
- Stiefel
- Stiefel Research Australia Pty. Ltd.
- Tesaro Inc.
- Total Support Management Group
- ViiV Healthcare
- Visiontech Inc.
- Wellcome Biotechnology Ltd.
- Wellcome Diagnostics
- Wellcome Foundation Ltd.
- Zambeletti SPA
- Senior Management
-
Emma Walmsley, CEO
Simon Dingemans, CFO
David Redfern, Chief Strategy Officer
Hal Barron, MD, Pres., R&D & CSO - Contact Info
-
GlaxoSmithKline PLC
Phone: (44) 20 8047 5000
980 Great West Rd.
Brentford, TW8 9GS
UK
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice